Logo

Metabolon to Collaborate with Mass General on ALS Biomarker Study

Aug 09, 2004

NEW YORK, Aug. 9 (GenomeWeb News) - Metabolon said today that it is collaborating with Massachusetts GeneralHospital on an amyotrophic lateral sclerosis biomarker study.

 

Under the collaboration, researchers from Metabolon and Mass General will work on identifying unique metabolic signatures for ALS as a means of developing a diagnostic test using biomarkers in cerebrospinal fluid and blood, the company said.

 

The study, being funded by the National Institute of Neurological Disorders and Stroke, is called Metabolic Signatures in ALS. Specific details of the Mass General collaboration were not disclosed.

 

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.